Alison L. Hannah - 14 May 2021 Form 3 Insider Report for RIGEL PHARMACEUTICALS INC (RIGL)

Role
Director
Signature
/s/ Dolly Vance (Attorney-in-Fact)
Issuer symbol
RIGL
Transactions as of
14 May 2021
Net transactions value
$0
Form type
3
Filing time
18 May 2021, 18:55:38 UTC
Next filing
21 May 2021

No securities are beneficially owned.